Black Diamond Therapeutics CEO David Epstein's 2021 pay jumps 32% to $5.1M
Black Diamond Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
Black Diamond Therapeutics reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, four executives at Black Diamond Therapeutics received on average a compensation package of $2.7M, a 1% decrease compared to previous year.
Average pay of disclosed executives at Black Diamond Therapeutics
David M. Epstein, Chief Executive Officer, received $5.1M in total, which increased by 32% compared to 2020. 83% of Epstein's compensation, or $4.2M, was in option awards. Epstein also received $229K in non-equity incentive plan, $538K in salary, as well as $88K in other compensation.
Brent Hatzis-Schoch, Chief Operating Officer, received a compensation package of $2M, which increased by 32% compared to previous year. 70% of the compensation package, or $1.4M, was in option awards.
Thomas Leggett, Chief Financial Officer, earned $1.9M in 2021.
Fang Ni, Chief Financial Officer, received $1.7M in 2021.
Related executives
You may also like
Source: SEC filing on April 28, 2022.